PROVECTUS BIOPHARMACEUTICALS, INC.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2022 | — | -346.6% | -359.4% |
| FY2023 | — | -520.2% | -556.2% |
| FY2024 | — | -734.4% | -766.9% |
| FY2025 | — | -1,575.3% | -1,615.8% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2022 | — | -346.6% | -359.4% |
| FY2023 | — | -520.2% | -556.2% |
| FY2024 | — | -734.4% | -766.9% |
| FY2025 | — | -1,575.3% | -1,615.8% |